Dysautonomia International   Report issue

Academic/Hospital Phase 2
Founded: East Moriches NY United States (2012)

Organization Overview

First Clinical Trial
2018
NCT03919773
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dysautonomia International

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Postural Orthostatic Tachycardia Syndrome (Phase 2)

Syndrome (Phase 2)

Tachycardia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4